Law Firm Article Australia: Regulatory shift provides opportunities for new methods of treatment using psychedelic substances

Authored by:  Suzy Madar , Matthew Swinn , Rosie Rand and Tim Craven On 3 February 2023, the Therapeutic Goods Administration (TGA) announced a major regulatory shift that will have significant impacts for the treatment of mental health conditions. Australia is now the first country to regulate psychedelic substances as medicines on national level.[1] In our recent article, we explored the most […]

Go to Source

Powered by WPeMatico